K. Luthman

发表

Accuracy of calculated pH-dependent aqueous drug solubility.

Christel A. S. Bergström, K. Luthman, P. Artursson, 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Absorption classification of oral drugs based on molecular surface properties.

Christel A. S. Bergström, K. Luthman, P. Artursson, 2003, Journal of medicinal chemistry.

Caco-2 monolayers in experimental and theoretical predictions of drug transport

K. Luthman, P. Artursson, K. Palm, 1996 .

Correlation of drug absorption with molecular surface properties.

K. Luthman, P. Artursson, A. Ungell, 1996, Journal of pharmaceutical sciences.

Optimization of isochromanone based urotensin II receptor agonists.

U. Hacksell, K. Luthman, E. Currier, 2010, Bioorganic & medicinal chemistry.

Design, parallel synthesis and SAR of novel urotensin II receptor agonists.

U. Hacksell, K. Luthman, E. Currier, 2007, European journal of medicinal chemistry.

Isochromanone-based urotensin-II receptor agonists.

U. Hacksell, K. Luthman, E. Currier, 2005, Bioorganic & medicinal chemistry.

Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1

Kristina Luthman, Per Artursson, K. Luthman, 2001 .

Mechanism of the antigen formation of carvone and related α, β‐unsaturated ketones

B. Gruvberger, K. Luthman, M. Bruze, 2001, Contact dermatitis.

Design, Synthesis and Evaluation of 2,5-Diketopiperazines as Inhibitors of the MDM2-p53 Interaction

K. Luthman, R. Guy, R. Kriwacki, 2015, PloS one.

An alpha,beta-unsaturated oxime identified as a strong contact allergen. Indications of antigen formation via several pathways.

K. Luthman, A. Nilsson, J. Nilsson, 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

An α, β-unsaturated oxime identified as a strong contact allergen: Indications of antigen formation via several pathways

K. Luthman, A. Nilsson, J. Nilsson, 2005 .

A conjugated diene identified as a prohapten: contact allergenic activity and chemical reactivity of proposed epoxide metabolites.

K. Luthman, A. Nilsson, J. Nilsson, 2005, Chemical research in toxicology.

Metabolic epoxidation of an alpha,beta-unsaturated oxime generates sensitizers of extreme potency. Are nitroso intermediates responsible?

K. Luthman, A. Karlberg, M. Bergström, 2007, Chemical research in toxicology.

Metabolic Epoxidation of an α,β-Unsaturated Oxime Generates Sensitizers of Extreme Potency. Are Nitroso Intermediates Responsible?

K. Luthman, A. Karlberg, Moa Andresen Bergström, 2007 .

Beta- and gamma-di- and tripeptides as potential substrates for the oligopeptide transporter hPepT1.

K. Luthman, P. Artursson, D. Seebach, 2007, Journal of medicinal chemistry.

The Phospholipid Vesicle-Based Drug Permeability Assay: 5. Development toward an Automated Procedure for High-Throughput Permeability Screening

M. Brandl, K. Luthman, U. Massing, 2009 .

Drug permeability across a phospholipid vesicle-based barrier 4. The effect of tensides, co-solvents and pH changes on barrier integrity and on drug permeability.

M. Brandl, K. Luthman, T. Vasskog, 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability.

M. Brandl, K. Luthman, G. Flaten, 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Drug permeability across a phospholipid vesicle-based barrier 2. Characterization of barrier structure, storage stability and stability towards pH changes.

M. Brandl, K. Luthman, H. Bunjes, 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Analogues of the epoxy resin monomer diglycidyl ether of bisphenol F: effects on contact allergenic potency and cytotoxicity.

K. Luthman, N. O’Boyle, A. Natsch, 2012, Chemical research in toxicology.

Inhibition of the sensitizing effect of carvone by the addition of non-allergenic compounds.

K. Luthman, A. Nilsson, J. Nilsson, 2004, Acta dermato-venereologica.

Conjugated dienes as prohaptens in contact allergy: in vivo and in vitro studies of structure-activity relationships, sensitizing capacity, and metabolic activation.

K. Luthman, J. Nilsson, A. Karlberg, 2006, Chemical research in toxicology.

Bioactivation of cinnamic alcohol forms several strong skin sensitizers.

K. Luthman, A. Karlberg, D. Ponting, 2014, Chemical research in toxicology.

Virtual Screening and Scaffold Hopping Based on GRID Molecular Interaction Fields

Ismael Zamora, Marie M. Ahlström, Marianne Ridderström, 2005, J. Chem. Inf. Model..

Allergic contact dermatitis--formation, structural requirements, and reactivity of skin sensitizers.

Kristina Luthman, Ann-Therese Karlberg, K. Luthman, 2008, Chemical research in toxicology.

Assessment of cross‐reactivity of new less sensitizing epoxy resin monomers in epoxy resin‐allergic individuals

K. Luthman, N. O’Boyle, A. Karlberg, 2016, Contact dermatitis.

Cinnamyl alcohol oxidizes rapidly upon air exposure

K. Luthman, A. Karlberg, T. Delaine, 2013, Contact dermatitis.

Antitumor activity of the alkylating oligopeptides J1 (L-melphalanyl-p-L-fluorophenylalanine ethyl ester) and P2 (L-prolyl-m-L-sarcolysyl-p-L-fluorophenylalanine ethyl ester): comparison with melphalan

K. Luthman, R. Lewensohn, R. Larsson, 2003, Anti-cancer drugs.

Novel and potent small-molecule urotensin II receptor agonists.

U. Hacksell, K. Luthman, E. Currier, 2009, Bioorganic & medicinal chemistry.

2,6,8-Trisubstituted 3-hydroxychromone derivatives as fluorophores for live-cell imaging.

K. Luthman, M. Grøtli, L. M. Wilhelmsson, 2009, Chemistry.

Can the epoxides of cinnamyl alcohol and cinnamal show new cases of contact allergy?

K. Luthman, A. Karlberg, L. Hagvall, 2018, Contact dermatitis.

Antitumor activity of the novel melphalan containing tripeptide J3 (L-prolyl-L-melphalanyl-p-L-fluorophenylalanine ethyl ester): comparison with its m-L-sarcolysin analogue P2.

K. Luthman, R. Lewensohn, R. Larsson, 2003, Molecular cancer therapeutics.

Synthesis of 1,2,4-Oxadiazole-, 1,3,4-Oxadiazole-, and 1,2,4-Triazole-Derived Dipeptidomimetics

U. Hacksell, K. Luthman, S. Borg, 1995 .

Synthesis and Evaluation of Substituted Chroman-4-one and Chromone Derivatives as Sirtuin 2-Selective Inhibitors

T. Suuronen, M. Lahtela-Kakkonen, K. Luthman, 2012, Journal of medicinal chemistry.

Identification of the Binding Site of Chroman-4-one-Based Sirtuin 2-Selective Inhibitors using Photoaffinity Labeling in Combination with Tandem Mass Spectrometry.

K. Luthman, C. Sihlbom, J. Lengqvist, 2016, Journal of medicinal chemistry.

Synthesis of 2-alkyl-substituted chromone derivatives using microwave irradiation.

K. Luthman, M. Grøtli, Christine Dyrager, 2009, The Journal of organic chemistry.

Pseudopeptides with a centrally positioned alkene -based disulphide bridge mimetic stimulate kallikrein-related peptidase 3 activity

Erik A. A. Wallén, K. Luthman, H. Koistinen, 2013 .

KHMDS enhanced SmI(2)-mediated reformatsky type alpha-cyanation.

K. Luthman, M. Grøtli, Nils Pemberton, 2010, Organic letters.

Benzyl-5-[N-(tert-butoxycarbonyl)amino]-4-oxo-6-phenylhexanoate

K. Luthman, T. Lejon, J. Våbenø, 2005 .

Microwave assisted synthesis of spiro-2,5-diketopiperazines

K. Luthman, M. Grøtli, Marcus Tullberg, 2007 .

Synthesis of C-glycosides of 3-deoxy-D-manno-2-octulosonic acid (KDO). Stereoselectivity in an enolate reaction

K. Luthman, A. Claesson, M. Orbe, 1987 .

Allenes and Acetylenes. XVIII. Synthesis of 3-Pyrrolines by Silver(I)-catalyzed Cyclization of Allenic Amines.

K. Lempert, J. Møller, K. Luthman, 1979 .

Antitumor efficacy and acute toxicity of the novel dipeptide melphalanyl-p-L-fluorophenylalanine ethyl ester (J1) in vivo

K. Luthman, R. Lewensohn, R. Larsson, 2004, Investigational New Drugs.

Chemoenzymatic synthesis of enantiomerically enriched α-chiral 3-oxy-propionaldehydes by lipase-catalyzed kinetic resolution and desymmetrization

K. Luthman, D. Wiktelius, E. Larsson, 2006 .

Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant.

L. Björck, K. Luthman, B. Johansson, 2009, Bioorganic & medicinal chemistry.

Novel peptidomimetics: inhibitors of substance P endopeptidase☆

G. Lindeberg, L. Terenius, U. Hacksell, 1992 .

Nature-derived epoxy resins: Synthesis, allergenicity, and thermosetting properties of pinoresinol diglycidyl ether

K. Luthman, N. O’Boyle, A. Natsch, 2022, Toxicology and industrial health.

Peracid dependent stereoselectivity and functional group contribution to the stereocontrol of epoxidation of (E)-alkene dipeptide isosteres

K. Luthman, J. Gullbo, Annika Jenmalm Jensen, 2006 .

Synthesis of perhydro-1,4-ethano-1,5-naphthyridine and perhydro-4,7-ethanopyrrolo[3,2-b]pyridine derivatives: potential NK1-receptor antagonists. X-Ray molecular structures of (4aR,8S,8aR)-6-oxo-8-phenylperhydro-1,4-ethano-1,5-naphthyridine and (4aR,7R,8R,8aR)-7,8-diphenylperhydro-1,4-ethano-1,5-nap

U. Hacksell, K. Luthman, C. Fowler, 1995 .

Journal of the Royal Institute of Chemistry. January 1959

U. Hacksell, K. Luthman, C. Fowler, 1959 .

Taking control of P1, P1' and double bond stereochemistry in the synthesis of Phe-Phe (E)-alkene amide isostere dipeptidomimetics.

K. Luthman, D. Wiktelius, 2007, Organic & biomolecular chemistry.

Synthesis of Perhydro-1,4-ethano-1,5-naphthyridine and Perhydro-4,7-ethanopyrrolo(3,2-b)pyridine Derivatives: Potential NK1-Receptor Antagonists. X-Ray Molecular Structures of (4aR*,8S*,8aR*)-6-Oxo-8-phenylperhydro-1,4-ethano-1,5-naphthyridine and (4aR*,7R*,8R*,8aR*)-7,8-Diphenylperhydro-1,4-ethano-

U. Hacksell, K. Luthman, C. Fowler, 2010 .

Stereoselective Epoxidation of Phe-Gly and Phe-Phe Vinyl Isosteres

U. Hacksell, K. Luthman, Yi-lin Li, 1994 .

Design and synthesis of fluorinated Phe-Gly dipeptidomimetics

U. Hacksell, K. Luthman, R. Vollinga, 2002 .

Diastereoselective peracid epoxidation: Control of the face selectivity via functional group tuning and proper choice of epoxidation reagent

K. Luthman, Annika Jenmalm Jensen, A. Jensen, 1998 .

Stereoselective Epoxidation of Phe-Gly and Phe-Phe Vinyl Isosteres.

U. Hacksell, K. Luthman, Yi-lin Li, 1994 .

Efficient large scale microwave assisted Mannich reactions using substituted acetophenones

K. Luthman, F. Lehmann, Å. Pilotti, 2004, Molecular Diversity.

Chroman-4-one- and chromone-based sirtuin 2 inhibitors with antiproliferative properties in cancer cells.

M. Lahtela-Kakkonen, Erik A. A. Wallén, K. Luthman, 2014, Journal of medicinal chemistry.

3-Aminopiperidine-Based Peptide Analogues as the First Selective Noncovalent Inhibitors of the Bacterial Cysteine Protease IdeS

K. Luthman, J. Kihlberg, T. Fex, 2012, Journal of medicinal chemistry.

A scaffold replacement approach towards new sirtuin 2 inhibitors.

Erik A. A. Wallén, K. Luthman, T. Kokkola, 2019, Bioorganic & medicinal chemistry.

Design, synthesis, and evaluation of Phe-Gly mimetics: heterocyclic building blocks for pseudopeptides.

L. Terenius, K. Luthman, L. Terenius, 1999, Journal of medicinal chemistry.

Proline-mediated formation of novel chroman-4-one tetrahydropyrimidines

K. Luthman, M. Grøtli, M. Erdélyi, 2012 .

Novel L-Phe-Gly mimetics

U. Hacksell, K. Luthman, Ling Yi-lin, 1992 .

Stereoselective Epoxidation of Allylic Carbamates with m-Chloroperbenzoic Acid: The Role of Cooperative Coordination

U. Hacksell, K. Luthman, I. Csoeregh, 1995 .

Diastereoselective Reduction of a Chiral N-Boc-Protected δ-Amino-α,β-unsaturated γ-Keto Ester Phe-Gly Dipeptidomimetic

K. Luthman, M. Brisander, J. Våbenø, 2002 .

Diastereoselective Peracid Epoxidation: Control of the Face Selectivity via Functional Group Tuning and Proper Choice of Epoxidation Reagent.

K. Luthman, A. Jensen, 1998 .

CYP2C9 structure-metabolism relationships: optimizing the metabolic stability of COX-2 inhibitors.

Ismael Zamora, Marie M. Ahlström, Kristina Luthman, 2007, Journal of medicinal chemistry.

A biocatalytic route to P-chirogenic compounds by lipase-catalyzed desymmetrization of a prochiral phosphine-borane.

Magnus J. Johansson, K. Luthman, N. Kann, 2005, Organic letters.

Stereoselective synthesis of dipeptidomimetics using chiral allylic aziridines

K. Luthman, E. Larsson, Wei Berts, 2002 .

Inhibitors and promoters of tubulin polymerization: synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents.

Erik A. A. Wallén, K. Luthman, M. Grøtli, 2011, Bioorganic & medicinal chemistry.

A synthetic approach to 2,3,4-substituted pyridines useful as scaffolds for tripeptidomimetics

K. Luthman, J. Kihlberg, Stina Saitton, 2004 .

Synthesis of 3-aminomethyl-2-aryl- 8-bromo-6-chlorochromones.

Erik A. A. Wallén, K. Luthman, M. Grøtli, 2007, Organic letters.

Novel potent and efficacious nonpeptidic urotensin II receptor agonists.

U. Hacksell, K. Luthman, E. Currier, 2006, Journal of medicinal chemistry.

Investigation of D1 Receptor–Agonist Interactions and D1/D2 Agonist Selectivity Using a Combination of Pharmacophore and Receptor Homology Modeling

K. Luthman, L. Brive, P. Svensson, 2012, ChemMedChem.

Selective Pharmacophore Models of Dopamine D1 and D2 Full Agonists Based on Extended Pharmacophore Features

K. Luthman, L. Brive, P. Svensson, 2010, ChemMedChem.

On the use of C2-symmetric aziridines as chiral auxiliaries

K. Luthman, D. Tanner, A. Gogoll, 1994 .

Chiral discrimination of complexes between benzyloxycarbonylglycyl-l-proline and 4-hydroxy-2-dipropylaminoindan in ion-pair chromatography: A molecular mechanics study

U. Hacksell, K. Luthman, C. Pettersson, 1994 .

Synthesis of Pyrroles and a 1,2-Dihydropyrrolo[1,2-a]pyrazin-3(4H)-one Identified as Maillard Reaction Products.

K. Lempert, J. Møller, K. Luthman, 1979 .

Synthesis of C-(beta-D-glycosyl) analogues of 3-deoxy-D-manno-2-octulosonic acid (Kdo) as potential inhibitors of CMP-Kdo synthetase.

K. Luthman, A. Claesson, M. Orbe, 1990, Carbohydrate research.

Conformational analysis of isopropylidene-protected C-glycosyl derivatives of 3-deoxy-d-manno-2-octulosonic acid (Kdo) in the solid state and in solution

K. Luthman, I. Csöregh, A. Claesson, 1991 .

3′‐Keto‐1‐nitro‐2‐phenylspiro[cyclopropane‐3,2′‐quinuclidine]: Synthesis and reactions with nucleophiles

U. Hacksell, K. Luthman, Y. Besidsky, 1994 .

Efficient synthesis of 2,5-diketopiperazines using microwave assisted heating

K. Luthman, M. Grøtli, Marcus Tullberg, 2006 .

Efficient Synthesis of 2,5-Diketopiperazines Using Microwave-Assisted Heating.

K. Luthman, Marcus Tullberg, M. Groetli, 2006 .

Prediction of Membrane Permeability to Peptides from Calculated Dynamic Molecular Surface Properties

Kristina Luthman, Patric Stenberg, Per Artursson, 1999, Pharmaceutical Research.

Experimental and Computational Screening Models for Prediction of Aqueous Drug Solubility

Ulf Norinder, Kristina Luthman, Christel A. S. Bergström, 2002, Pharmaceutical Research.

Proline-Mediated Formation of Novel Chroman-4-one Tetrahydropyrimidines.

K. Luthman, M. Erdélyi, Maria Fridén-Saxin, 2013 .

Structural analogues inhibit the sensitizing capacity of carvone.

K. Luthman, A. Nilsson, J. Nilsson, 2001, Acta dermato-venereologica.

Epoxyalcohols: bioactivation and conjugation required for skin sensitization.

Per-Ola Norrby, Andreas Natsch, Kristina Luthman, 2014, Chemical research in toxicology.

Structural analysis of two 2-deoxy analogues of α- and β-KDO and the methyl α- and β-glycosides of KDO, and determination of their metal-ion-binding properties

K. Luthman, L. Kenne, I. Csöregh, 1987 .

Global and Local Computational Models for Aqueous Solubility Prediction of Drug-Like Molecules

Ulf Norinder, Kristina Luthman, Christel A. S. Bergström, 2004, J. Chem. Inf. Model..

Microwave-assisted solid-phase synthesis of 2,5-diketopiperazines: solvent and resin dependence.

K. Luthman, M. Grøtli, Marcus Tullberg, 2006, Journal of combinatorial chemistry.

Synthesis and reactivity of 6-carbamoyl-5-phenyl-2,3,5,6-tetrahydro-1H-1,4-ethanobenzo[f]quinoline. X-Ray molecular structure of (4aR,5S,6R,10bR)-5-phenyl-2,3,4a,5,6,10b-hexahydro-1H-1,4-ethanobenzo[f]quinolin-6-yl acetate

U. Hacksell, K. Luthman, I. Csöregh, 1995 .

Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans

Kristina Luthman, Patric Stenberg, K. Luthman, 1997, Pharmaceutical Research.

Synthesis of alpha,beta-Unsaturated Analogues of KDO and N-Acetylneuraminic Acid by Trimethylsilyl Triflate-catalyzed Elimination Reactions.

K. Luthman, A. Claesson, Curtis L. Leicht, 1982 .

Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs.

K. Luthman, P. Artursson, K. Palm, 1999, The Journal of pharmacology and experimental therapeutics.

Investigation of D2 Receptor–Agonist Interactions Using a Combination of Pharmacophore and Receptor Homology Modeling

K. Luthman, L. Brive, P. Svensson, 2012, ChemMedChem.

Novel heterocycles derived from 3‐acyloxy‐ and 3‐acetamidoquinuclidines

U. Hacksell, K. Luthman, Y. Besidsky, 1994 .

Synthesis of analogues of 3-deoxy-D-manno-octulosonic acid (KDO) as potential inhibitors of CMP-KDO synthetase.

K. Luthman, A. Jansson, A. Claesson, 1987, Carbohydrate research.

A 2-deoxy analogue of KDO as the first inhibitor of the enzyme CMP-KDO synthetase.

K. Luthman, G. Bondesson, A. Claesson, 1987, Biochemical and biophysical research communications.

Conformational restrictions in ligand binding to the human intestinal di-/tripeptide transporter: implications for design of hPEPT1 targeted prodrugs.

I. Sylte, K. Luthman, F. Jørgensen, 2005, Bioorganic & medicinal chemistry.

Novel Heterocycles Derived from 3-Acyloxy- and 3- Acetamidoquinuclidines.

U. Hacksell, K. Luthman, Y. Besidsky, 1995 .

Caco-2 monolayers in experimental and theoretical predictions of drug transport.

K. Luthman, P. Artursson, K. Palm, 2001, Advanced drug delivery reviews.

Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion.

M. Brandl, K. Luthman, G. Flaten, 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Theoretical Predictions of Drug Absorption in Drug Discovery and Development

Kristina Luthman, Christel A. S. Bergström, Christel A S Bergström, 2002, Clinical pharmacokinetics.

Experimental and computational screening models for the prediction of intestinal drug absorption.

U Norinder, K. Luthman, P. Artursson, 2001, Journal of medicinal chemistry.

1,2,4-Oxadiazole derivatives of phenylalanine: potential inhibitors of substance P endopeptidase

L. Terenius, U. Hacksell, K. Luthman, 1993 .

Chroman-4-one and chromone based somatostatin β-turn mimetics.

Erik A. A. Wallén, K. Luthman, M. Grøtli, 2016, European journal of medicinal chemistry.

Design, synthesis, tandem mass spectrometric sequencing and biological activity of NGF mimetics.

K. Kullander, U. Hacksell, K. Luthman, 2009, International journal of peptide and protein research.

Prediction of the Intestinal Absorption of Endothelin Receptor Antagonists Using Three Theoretical Methods of Increasing Complexity

J. D. Elliott, Kristina Luthman, Harma Ellens, 1999, Pharmaceutical Research.

Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors.

K. Luthman, P. Artursson, A. Ungell, 1998, Journal of medicinal chemistry.

Epoxy resin monomers with reduced skin sensitizing potency.

K. Luthman, N. O’Boyle, K. Holmberg, 2014, Chemical research in toxicology.

Structure--activity relationship between the in vivo skin sensitizing potency of analogues of phenyl glycidyl ether and the induction of Nrf2-dependent luciferase activity in the KeratinoSens in vitro assay.

Andreas Natsch, Kristina Luthman, Roger Emter, 2011, Chemical research in toxicology.

Impact of a heteroatom in a structure-activity relationship study on analogues of phenyl glycidyl ether (PGE) from epoxy resin systems.

K. Luthman, A. Karlberg, T. Delaine, 2011, Chemical research in toxicology.

Reduced sensitizing capacity of epoxy resin systems: a structure-activity relationship study.

K. Luthman, A. Karlberg, C. Jonsson, 2009, Chemical research in toxicology.

Role of the subunit composition of central nicotinic acetylcholine receptors for the stimulatory and dopamine-enhancing effects of ethanol.

K. Luthman, M. Grøtli, E. Jerlhag, 2006, Alcohol and alcoholism.

Structure-activity relationship for alkylating dipeptide nitrogen mustard derivatives.

K. Luthman, R. Lewensohn, R. Larsson, 2003, Oncology research.

Microwave-assisted synthesis of the Schöllkopf chiral auxiliaries: (3S)- and (3R)-3,6-dihydro-2,5-diethoxy-3-isopropyl-pyrazine

K. Luthman, M. Grøtli, P. Ioannidis, 2006 .

Synthesis of functionalized, unsymmetrical 1,3,4,6-tetrasubstituted 2,5-diketopiperazines.

K. Luthman, M. Grøtli, Marcus Tullberg, 2007, The Journal of organic chemistry.

Virtual screening of intestinal drug permeability.

K. Luthman, P. Artursson, P Artursson, 2000, Journal of controlled release : official journal of the Controlled Release Society.

Molecular Descriptors Influencing Melting Point and Their Role in Classification of Solid Drugs

Ulf Norinder, Kristina Luthman, Christel A. S. Bergström, 2003, J. Chem. Inf. Comput. Sci..

Activity of Hydrolytic Enzymes in Tumour Cells is a Determinant for Anti-tumour Efficacy of the Melphalan Containing Prodrug J1

K. Luthman, R. Lewensohn, R. Larsson, 2003, Journal of drug targeting.

Stereoselectivity of Drug Receptor Interactions

S. Hjorth, L. Arvidsson, U. Hacksell, 1990 .

Modelling of Drug–Receptor Interactions: Stereoselectivity of 5-Hydroxytryptamine and Dopamine Receptors in the Brain

U. Hacksell, K. Luthman, C. Mellin, 1990 .

Molecular Descriptors Influencing Melting Point and Their Role in Classification of Solid Drugs.

Ulf Norinder, Kristina Luthman, Per Artursson, 2003 .

Nature-Derived Epoxy Resin Monomers with Reduced Sensitizing Capacity—Isosorbide-Based Bis-Epoxides

K. Luthman, A. Karlberg, Isabella Karlsson, 2023, Chemical research in toxicology.

Inside Cover: Selective Pharmacophore Models of Dopamine D1 and D2 Full Agonists Based on Extended Pharmacophore Features (ChemMedChem 2/2010)

K. Luthman, L. Brive, P. Svensson, 2010 .

Development of 7TM receptor-ligand complex models using ligand-biased, semi-empirical helix-bundle repacking in torsion space: application to the agonist interaction of the human dopamine D2 receptor

Lars Brive, Kristina Luthman, Peder Svensson, 2013, Journal of Computer-Aided Molecular Design.

Synthesis and evaluation of novel pyridine based PLG tripeptidomimetics.

K. Luthman, J. Kihlberg, Andria L. Del Tredici, 2008, Organic & biomolecular chemistry.

Design, synthesis and evaluation of a PLG tripeptidomimetic based on a pyridine scaffold.

K. Luthman, J. Kihlberg, D. Boström, 2004, Journal of medicinal chemistry.

Sequence dependence of DNA structure. The B, Z, and A conformations of polydeoxynucleotides containing repeating units of 6 to 16 base pairs.

K. Luthman, M. Behe, 1988, The Journal of biological chemistry.

Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability.

M. Brandl, K. Luthman, G. Flaten, 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Drug permeability across a phospholipid vesicle-based barrier 4. The effect of tensides, co-solvents and pH changes on barrier integrity and on drug permeability.

M. Brandl, K. Luthman, T. Vasskog, 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.